Page last updated: 2024-11-05

troglitazone and Metastase

troglitazone has been researched along with Metastase in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research Excerpts

ExcerptRelevanceReference
"Osteosarcoma often develops micrometastases in the lung prior to diagnosis, causing a fatal outcome."5.36Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8. ( Aizawa, J; Kamei, S; Kidani, T; Masuno, H; Norimatsu, Y; Sakayama, K; Yamamoto, H, 2010)
"Osteosarcoma often develops micrometastases in the lung prior to diagnosis, causing a fatal outcome."1.36Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8. ( Aizawa, J; Kamei, S; Kidani, T; Masuno, H; Norimatsu, Y; Sakayama, K; Yamamoto, H, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aizawa, J1
Sakayama, K1
Kamei, S1
Kidani, T1
Yamamoto, H1
Norimatsu, Y1
Masuno, H1

Other Studies

1 other study available for troglitazone and Metastase

ArticleYear
Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8.
    BMC cancer, 2010, Feb-22, Volume: 10

    Topics: Animals; Antigens, CD34; Cell Line, Tumor; Chromans; Humans; Hypoglycemic Agents; Lung Neoplasms; Ma

2010